when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

ASTRAZENECA · news · pharmadog

← back to ASTRAZENECA

News mentioning ASTRAZENECA

209 stories

Jul 9, 26AstraZeneca, Ionis drug fails big heart disease study in major setbackbiopharma dive

Jul 9, 26STAT+: AstraZeneca, Ionis report major trial failure with heart disease drugstat

Jul 9, 26Updated: AstraZeneca sinks on unexpected heart drug trial failureendpoints

Jul 8, 26AstraZeneca, GSK intensify China ties with Sino Biopharm dealsbiopharma dive

Jul 8, 26STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and morestat

Jul 8, 26Sino Biopharm hooks AstraZeneca, GSK for separate respiratory partnershipsendpoints

Jul 6, 26Novartis to acquire ADC developer in a deal worth up to $1.5Bbiopharma dive

Jul 2, 26STAT+: Up and down the ladder: The latest comings and goingsstat

Jul 2, 26After landmark deal, AstraZeneca goes to CSPC again in up to $1.7B pactendpoints

Jul 2, 26STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and morestat

Jul 2, 26STAT+: U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drugstat

Jul 1, 26STAT+: Pharmalittle: We’re reading about Anthropic drug development goals, Trump drug plan snags, and morestat

Jun 30, 26Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot programbiopharma dive

Jun 30, 26STAT+: Pharmalittle: We’re reading about Chinese trial sites being probed, RFK Jr. and peptides, and morestat

Jun 29, 26STAT+: AstraZeneca to pay $34 million to settle kickback charges filed by Texas attorney generalstat

Jun 29, 26Biotech SPAC deal gets it to Nasdaq; AstraZeneca Phase 3 win in bone diseaseendpoints

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 26, 26FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences servicesbiopharma dive

Jun 26, 26On second try, Acadia drug gets nod from European regulatorsbiopharma dive

Jun 12, 26STAT+: Up and down the ladder: The latest comings and goingsstat

Jun 12, 26STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and morestat

Jun 11, 26STAT+: An obesity drug deep-dive, and peptides move mainstreamstat

Jun 11, 26STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and morestat

Jun 10, 26STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and morestat

Jun 10, 26AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicinebiopharma dive

Jun 9, 26STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis findsstat

Jun 9, 26Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cutsstat

Jun 9, 26FDA OKs first new sunscreen ingredient in more than 25 yearsstat

Jun 9, 26Gilead and Merck’s latest trial success and flopstat

Jun 9, 26STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and morestat

← prevpage 5 of 7next →